GUTS Earnings Date: Nov 11, 2026 (Estimated) — Fractyl Health, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is GUTS's next earnings date?
Fractyl Health, Inc. (GUTS) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.59.
How did GUTS do in its last earnings report?
In its most recent report on Aug 11, 2026, Fractyl Health, Inc. posted EPS of -$23.04 versus the -$19.44 estimate, a miss. The stock's 1-day post-earnings move was +3.1%.
How much does GUTS stock move after earnings?
GUTS beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.2% (up or down) in the day after earnings.
About Fractyl Health, Inc.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | -19.44 | -23.04 | — | — | ❌ Miss | +3.11% | -2.22% | -5.19% | |
| 2026-08-10 | Q2 2026 | — | -1.92 | -14.29% | $0 | ❌ Miss | +3.98% | -2.22% | -5.19% |
| 2026-05-12 | Q1 2026 | -1.92 | 0.72 | +137.50% | $0 | ✅ Beat | +29.20% | +11.32% | -1.38% |
| 2026-03-24 | Q4 2025 | -2.16 | -0.84 | +61.11% | $0 | ✅ Beat | +16.17% | +6.37% | +34.99% |
| 2025-11-12 | Q3 2025 | -3.96 | -8.52 | -115.15% | $0 | ❌ Miss | -0.89% | +17.70% | +98.23% |
| 2025-08-12 | Q2 2025 | -4.32 | -6.84 | -58.33% | $0 | ❌ Miss | +2.65% | +0.72% | +3.67% |
| 2025-03-03 | Q4 2024 | -5.28 | -6.24 | -18.18% | $3,000 | ❌ Miss | -3.85% | -8.33% | -28.85% |
| 2024-08-14 | Q2 2024 | -5.52 | -4.32 | +21.74% | $43,000 | ✅ Beat | +5.38% | +34.53% | +25.11% |
Showing last 8 quarters.